Skip to content

Clinical application of oro-nasal conversion auxiliary device for nasobiliary duct

Clinical application of oro-nasal conversion auxiliary device for nasobiliary duct

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073464
Enrollment
Unknown
Registered
2023-07-11
Start date
2021-01-18
Completion date
Unknown
Last updated
2023-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

biliary disease

Interventions

Guide wire combined with syringe group:1ml syringe outer cannula combined with traditional guidewire technology
Control group:Traditional guidewire technique

Sponsors

Xiangtan Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 88 Years

Inclusion criteria

Inclusion criteria: We select patients aged above 18 years who undergo the ENBD procedure for biliary disease.

Exclusion criteria

Exclusion criteria: (1) history of oral-nasopharynx tumor or surgery, (2) the carrier catheter (8Fr) could not pass or did not pass smoothly due to the deformity of the nasopharynx,(3)inability to provide informed consent.

Design outcomes

Primary

MeasureTime frame
the conversion time;

Secondary

MeasureTime frame
the number of conversion;the success rate of the procedures;

Countries

China

Contacts

Public ContactQunqing liu

Xiangtan Central Hospital

liu_qq71@163.com+86 13973244413

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026